ONCO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Onconetix Inc (ONCO) does not present a compelling buy opportunity for a beginner long-term investor at this time. The stock is currently in a bearish technical setup, with pre-market trading showing a significant decline of -10.03%. Additionally, the company's financial performance is weak, with declining revenue and negative EPS. While the merger with Realbotix could be a positive catalyst in the long term, the immediate outlook remains uncertain, and there are no strong trading signals or significant insider/hedge fund activity to support a buy decision.
The stock is in a bearish trend with SMA_200 > SMA_20 > SMA_5. RSI is neutral at 36.764, and the MACD histogram is positive but contracting. Key support levels are at S1: 1.123 and S2: 0.934, with the pre-market price nearing S2. The stock is under pressure, with no clear bullish signals.
The merger with Realbotix and the strategic consolidation effort could enhance Onconetix's market position in the long term.
The stock is down -10.03% in pre-market trading, reflecting negative sentiment. Financial performance is weak, with declining revenue (-25.37% YoY) and negative EPS (-97.49% YoY).
In Q3 2025, revenue dropped by -25.37% YoY to 303,651. Net income improved but remains negative at -8,783,702. EPS declined significantly to -6.25, down -97.49% YoY. Gross margin increased to 88.55%, up 241.76% YoY, but this improvement is overshadowed by the overall weak financials.
No analyst rating or price target data available.
